In the United States, pharmaceutical advertising has undergone a profound transformation, evolving from the dubious claims of patent medicines in the 18th and 19th centuries to the contemporary landscape dominated by digital marketing and direct-to-consumer advertising (DTCA). As spending on pharmaceutical advertising soared to approximately $6.88 billion in 2021, the industry grapples with the complexities of marketing its products and with ethical considerations and regulatory frameworks aimed at protecting consumers.
Read More.